Statistics for Collegium Pharmaceutical (id:7866 COLL)

Valuation metrics

Market cap

967.51M

Enterprise value

1.69B

Trailing P/E (ttm)

12.82

Forward P/E

4.50

PEG ratio

4.50

Price/Sales (ttm)

1.61

Price/Book (mrq)

4.13

Enterprise Value/Revenue

2.82

Enterprise Value/EBITDA

4.62

Overview

Shares outstanding

32.25M

Float

29.53M

Shares short

6.21M

% Held by insiders

0.02%

% Held by institutions

1.22%

Average volume (10 days)

612.82K

Average volume (90 days)

Price summary

52-Week low

25.16

52-Week high

42.29

52-Week change

13.20%

Beta

0.95

50-Day moving average

36.21

200-Day moving average

35.45

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

14.78%

Operating margin

35.17%

Operational effectiveness

Return on assets

9.68%

Return on equity

42.89%

Income statement

Revenue (ttm)

18.54

Revenue per share (ttm)

18.54

Quarterly revenue growth (yoy)

-0.55

Gross profit (ttm)

326.17M

EBITDA

358.05M

Net income to common (ttm)

88.59M

Diluted EPS (ttm)

2.34

Quarterly earnings growth (yoy)

-54.80%

Balance sheet

Total cash (mrq)

144.96M

Total cash per share (mrq)

4.50

Total debt (mrq)

874.40M

Total Debt/Equity (mrq)

373.23

Current ratio (mrq)

96.60%

Book value per share (mrq)

7.27

Cash flow

Cash flow statement

193.67M

Levered free cash flow (LFCF)

324.09M